- Home
- RAYA vs OCX Comparison
RAYA vs OCX Comparison
Compare RAYA & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- OCX
- Stock Information
- Founded
- RAYA 2019
- OCX 2009
- Country
- RAYA China
- OCX United States
- Employees
- RAYA N/A
- OCX N/A
- Industry
- RAYA Metal Fabrications
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RAYA Consumer Discretionary
- OCX Health Care
- Exchange
- RAYA Nasdaq
- OCX Nasdaq
- Market Cap
- RAYA 32.5M
- OCX 38.7M
- IPO Year
- RAYA 2022
- OCX N/A
- Fundamental
- Price
- RAYA $1.17
- OCX $2.66
- Analyst Decision
- RAYA
- OCX Buy
- Analyst Count
- RAYA 0
- OCX 3
- Target Price
- RAYA N/A
- OCX $4.42
- AVG Volume (30 Days)
- RAYA 49.9K
- OCX 64.9K
- Earning Date
- RAYA 07-09-2024
- OCX 11-12-2024
- Dividend Yield
- RAYA N/A
- OCX N/A
- EPS Growth
- RAYA N/A
- OCX N/A
- EPS
- RAYA N/A
- OCX N/A
- Revenue
- RAYA $22,816,585.00
- OCX $709,000.00
- Revenue This Year
- RAYA $64.53
- OCX N/A
- Revenue Next Year
- RAYA $9.61
- OCX $167.93
- P/E Ratio
- RAYA N/A
- OCX N/A
- Revenue Growth
- RAYA N/A
- OCX N/A
- 52 Week Low
- RAYA $0.44
- OCX $2.29
- 52 Week High
- RAYA $1.78
- OCX $4.31
- Technical
- Relative Strength Index (RSI)
- RAYA 49.15
- OCX 39.09
- Support Level
- RAYA $1.03
- OCX $2.50
- Resistance Level
- RAYA $1.24
- OCX $3.04
- Average True Range (ATR)
- RAYA 0.15
- OCX 0.17
- MACD
- RAYA -0.04
- OCX -0.03
- Stochastic Oscillator
- RAYA 18.95
- OCX 29.96
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.